SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-009649
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:53
Documents
61
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vor-20220331.htm   iXBRL 10-Q 2543930
2 EX-31.1 vor-ex31_1.htm EX-31.1 20270
3 EX-31.2 vor-ex31_2.htm EX-31.2 20274
4 EX-32.1 vor-ex32_1.htm EX-32.1 22782
  Complete submission text file 0000950170-22-009649.txt   7557818

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vor-20220331.xsd EX-101.SCH 39148
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vor-20220331_lab.xml EX-101.LAB 329706
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vor-20220331_def.xml EX-101.DEF 121885
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vor-20220331_pre.xml EX-101.PRE 229907
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vor-20220331_cal.xml EX-101.CAL 38612
55 EXTRACTED XBRL INSTANCE DOCUMENT vor-20220331_htm.xml XML 1342222
Mailing Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 430 CAMBRIDGE MA 02142 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39979 | Film No.: 22917796
SIC: 2836 Biological Products, (No Diagnostic Substances)